Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: September 20, 2010
Last updated: August 13, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)